MedMira Unaware of Any Material Change
(firmenpresse) - HALIFAX, NOVA SCOTIA -- (Marketwired) -- 03/09/17 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), at the request of IIROC, wishes to confirm that the Company''s management is unaware of any material change in the Company''s operations that would account for the recent increase in market activity.
About MedMira
MedMira is the developer and owner of Rapid Vertical Flow (RVF) Technologya. The Company''s rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as HIV and hepatitis C in just three easy steps. The Company''s tests are sold under the Reveal, Multiplo and Miriad™ brands in global markets. MedMira''s corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada and the Company has a sales and customer service office located in the United States. For more information visit . Follow us on and .
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain assumptions, estimates, and other forward-looking statements regarding future events. Such forward-looking statements involve inherent risks and uncertainties and are subject to factors, many of which are beyond the Company''s control that may cause actual results or performance to differ materially from those currently anticipated in such statements.
Contacts:
MedMira Inc.
Hermes Chan
CEO
902 450 1588
MedMira Inc.
Andrea Young
Corporate Communications
902-450-1588
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.03.2017 - 10:37 Uhr
Sprache: Deutsch
News-ID 1491727
Anzahl Zeichen: 3423
contact information:
Contact person:
Town:
HALIFAX, NOVA SCOTIA
Phone:
Kategorie:
Medical Devices
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 283 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MedMira Unaware of Any Material Change
"
steht unter der journalistisch-redaktionellen Verantwortung von
MedMira Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).